Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness.
The populations of group B streptococcus (GBS) associated with vaginal carriage in pregnant women and invasive neonatal infections in Portugal were compared. GBS isolates were characterized by serotyping, pulsed-field gel electrophoresis (PFGE) profiling, and multilocus sequence typing (MLST). Serotypes III and V accounted for 44% of all colonization isolates (n = 269), whereas serotypes III and Ia amounted to 69% of all invasive isolates (n = 64). Whereas serotype Ia was associated with early-onset disease (EOD), serotype III was associated with late-onset disease (LOD). Characterization by PFGE and MLST identified very diverse populations in carriage and invasive disease. Serotype Ia was represented mainly by a single PFGE cluster defined by sequence type 23 (ST23) and the infrequent ST24. In contrast, serotype III was found in a large number of PFGE clusters and STs, but a single PFGE cluster defined by ST17 was found to be associated with invasive disease. Although serotype III was associated only with LOD, ST17 showed an enhanced capacity to cause both EOD and LOD. Our data reinforce the evidence for enhanced invasiveness of ST17 and identify a lineage expressing serotype Ia capsule and represented by ST23 and ST24 as having enhanced potential to cause EOD.
Martins
E R
ER
Instituto de Microbiologia, Faculdade Medicina Lisboa, Universidade de Lisboa, Av. Egas Moniz, PT 1649-028 Lisbon, Portugal.
Pessanha
M A
MA
Ramirez
M
M
Melo-Cristino
J
J
D002353:Carrier State / Q000382:microbiology*; D016521:Electrophoresis, Gel, Pulsed-Field; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D011247:Pregnancy; D017422:Sequence Analysis, DNA; D012703:Serotyping; D013290:Streptococcal Infections / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000145:classification* / Q000235:genetics / Q000472:pathogenicity; D014621:Vagina / Q000382:microbiology*
J Clin Microbiol. 1977 Aug;6(2):136-9
330561
Epidemiol Infect. 2004 Dec;132(6):1083-90
15635965
Clin Microbiol Infect. 2000 Jan;6(1):9-13
11168030
FEMS Immunol Med Microbiol. 2003 May 15;36(1-2):111-3
12727374
Clin Microbiol Rev. 1998 Jul;11(3):497-513
9665980
J Clin Microbiol. 2006 Apr;44(4):1257-61
16597848
MMWR Morb Mortal Wkly Rep. 2005 Dec 2;54(47):1205-8
16319814
Br Med J (Clin Res Ed). 1981 Aug 15;283(6289):459-61
6790015
J Clin Microbiol. 1995 Sep;33(9):2233-9
7494007
Clin Microbiol Infect. 2003 Aug;9(8):832-8
14616704
Microbiology (Reading). 2005 Jun;151(Pt 6):1875-1881
15941995
J Infect Dis. 1998 Apr;177(4):998-1002
9534974
J Clin Microbiol. 2005 Apr;43(4):1706-15
15814989
Pediatr Infect Dis J. 2001 Sep;20(9):879-84
11734768
Eur J Obstet Gynecol Reprod Biol. 2008 Feb;136(2):265-7
17134816
Clin Infect Dis. 2004 May 1;38(9):1203-8
15127328
J Clin Microbiol. 2004 May;42(5):2161-7
15131184
J Clin Microbiol. 2000 Sep;38(9):3420-8
10970395
J Bacteriol. 2004 Mar;186(5):1518-30
14973027
J Clin Microbiol. 2006 Jul;44(7):2524-32
16825375
Lancet. 1999 Jan 2;353(9146):51-6
10023965
J Clin Microbiol. 2007 Apr;45(4):1360-2
17267636
J Clin Microbiol. 2003 Jun;41(6):2530-6
12791877
J Clin Pathol. 1971 Jul;24(5):438-41
5571836
Vaccine. 2005 May 2;23(24):3187-95
15837219
J Infect. 2002 Jul;45(1):42-6
12217731
Microb Drug Resist. 2004 Spring;10(1):31-6
15140391
J Clin Microbiol. 2005 Nov;43(11):5483-90
16272474
J Infect Dis. 2003 May 1;187(9):1424-32
12717624
Arch Dis Child Fetal Neonatal Ed. 2001 Mar;84(2):F85-9
11207221
Clin Infect Dis. 2006 Apr 1;42(7):915-24
16511753
Pediatrics. 1977 May;59(5):679-82
323810
J Korean Med Sci. 2006 Apr;21(2):347-50
16614527
Science. 2005 Jul 1;309(5731):148-50
15994562
J Clin Microbiol. 2004 Jan;42(1):83-9
14715736